Viewsroom: Short squeeze craziness, Oz in the lead
Something completely wacky is happening with GameStop and a few other stocks favored by short sellers, and it’s likely to end very poorly for some armchair traders, Breakingviews columnists discuss. P...
28 Jan 202124min
Viewsroom: Biden’s inauguration, China’s stresses
The new U.S. president arrives with a long to-do list, good intentions and a swelling national debt pile. Gina Chon and Richard Beales talk with John Foley about what to expect. Plus: New lockdowns br...
21 Jan 202123min
Viewsroom: Predictions and prescriptions (Part 2)
A Joe Biden-Xi Jinping reset will be unsatisfying; China’s economic revival will frustrate critics; Southeast Asia will be the next tech hot spot; HSBC will retreat from America; and Hong Kong’s excha...
31 Des 202023min
Viewsroom: Predictions and prescriptions (Part 1)
Governments will become activist investors; U.S. airlines will merge; data centres will be the new ESG target; energy giants to consider renewable spinoffs; Tesla will buy Daimler; European soccer get...
23 Des 202025min
Viewsroom: Bank dividends and Chinese rentals
European regulators’ cautious lifting of a ban on bank dividends leaves investors in limbo, plus details of an unusually bold growth strategy from Credit Suisse. And the collapse of China’s WeWork-lik...
17 Des 202026min
Viewsroom: Davos in Singapore, Bob Dylan sells out
The World Economic Forum’s decision to hold its annual chinwag in Southeast Asia instead of Switzerland this coming spring isn’t as simple as it sounds, Davos vets Peter Thal Larsen and Una Galani tel...
10 Des 202023min
Viewsroom: Biden’s money team, Bank boss shuffle
The American president-elect has put forward a diverse and competent team of people to oversee economic policy, including Janet Yellen at Treasury. Across the pond, European banks engage in a bit of C...
3 Des 202031min
Viewsroom: Vaccines suggest light at tunnel’s end
Moderna and Pfizer came out with encouraging news on the fight to immunize the world against COVID-19, giving hope the pandemic’s end is near. Meantime, China’s Sinovac finds its trials are undermined...
19 Nov 202026min
